Investigation Report on Chinese Insulin Glargine Market, 2018-2022

SKU ID :CRI-12905849 | Published Date: 06-Aug-2018 | No. of pages: 30
Table of Contents 1 Relevant Concepts of Insulin Glargine 1.1 Indications for Insulin Glargine 1.2 Development History of Insulin Glargine in China 1.3 Patents and Government Approval on Insulin Glargine in China 2 Sales of Insulin Glargine in China, 2013-2017 2.1 Sales Value of Insulin Glargine 2.1.1 Overall Sales Value 2.1.2 Sales Value by Region 2.2 Sales Volume of Insulin Glargine 2.2.1 Overall Sales Volume 2.2.2 Sales Volume by Region 2.3 Sales of Insulin Glargine by Dosage Form in China, 2013-2017 3 Analysis on Major Insulin Glargine Manufacturers in China, 2013-2017 3.1 Analysis on Market Share of Major Insulin Glargine Manufacturers 3.1.1 Market Share by Sales Value 3.1.2 Market Share by Sales Volume 3.2 Aventis Behring 3.2.1 Enterprise Profile 3.2.2 Sales of Aventis Behring's Insulin Glargine in China 3.3 Gan & Lee Pharmaceuticals 3.3.1 Enterprise Profile 3.3.2 Sales of Gan & Lee Pharmaceuticals' Insulin Glargine in China 3.4 Zhuhai United Laboratories Co., Ltd. 3.4.1 Enterprise Profile 3.4.2 Sales of Zhuhai United Laboratories Co., Ltd.'s Insulin Glargine in China 4 Prices of Different Manufacturers' Insulin Glargine in China, 2017-2018 4.1 Overview 4.2 Aventis Behring (Lantus) 4.3 Gan & Lee Pharmaceuticals (Changxiulin) 4.4 Zhuhai United Laboratories Co., Ltd. (USLEN) 5 Prospect of Chinese Insulin Glargine Market, 2018-2022 5.1 Analysis on Factors Influencing Development 5.2 Forecast on Market Trend 5.3 Analysis on Generic Drugs in Development Selected Charts Chart Governmental Approval of Insulin Glargine in China Chart Sales Value of Insulin Glargine in China, 2013-2017 Chart Sales Value of Insulin Glargine in Parts of China, 2013-2017 Chart Sales Volume of Insulin Glargine in China, 2013-2017 Chart Sales Value and Market Share of Aventis Behring’s Insulin Glargine in China, 2013-2017 Chart Sales Value and Market Share of Gan & Lee Pharmaceuticals' Insulin Glargine in China, 2013-2017 Chart Sales Value and Market Share of Zhuhai United Laboratories Co., Ltd.'s Insulin Glargine in China, 2013-2017 Chart Sales Value and Market Share of Insulin Glargine Injections in China, 2013-2017 Chart Prices of Aventis Behring's Insulin Glargine in Parts of China, 2017-2018 Chart Prices of Gan & Lee Pharmaceuticals' Insulin Glargine in Parts of China, 2017-2018 Chart Prices of Zhuhai United Laboratories Co., Ltd.'s Insulin Glargine in Parts of China, 2017-2018 Chart Forecast on Sales Value of Insulin Glargine in China, 2018-2012
Aventis Behring Gan & Lee Pharmaceuticals Zhuhai United Laboratories Co., Ltd.
  • PRICE
  • $2200
    $3300
    Buy Now

Our Clients